Trial Profile
A study to evaluate the pregnancy outcomes in patients with Psoriasis and Psoriatic Arthritis treated with Ustekinumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2016
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Plaque psoriasis; Psoriatic arthritis
- Focus Adverse reactions
- 05 Apr 2016 New trial record
- 08 Mar 2016 Results presented at the 74th Annual Meeting of the American Academy of Dermatology